From the Division of Plastic and Reconstructive Surgery, Department of Surgery.
Department of Emergency Medicine, Kaohsiung Veterans General Hospital, Kaohsiung.
Ann Plast Surg. 2022 Mar 1;88(1s Suppl 1):S99-S105. doi: 10.1097/SAP.0000000000003069.
Necrotizing fasciitis (NF) is a life-threatening disease with a fulminant presentation. Although early diagnosis can be aided by combining physical examination, the Laboratory Risk Indicator for Necrotizing Fasciitis score, and computed tomography, a mortality rate of 30% is still reported. In the modern times, an economical and efficient biomarker for predicting mortality in NF patients is still lacking. Platelet count is typically measured in routine blood tests and aids in predicting disease severity. We aimed to clarify the role of platelet count as a predictive factor for aspects of prognosis, such as mortality and surgical outcomes, in patients with NF.
We identified 285 patients with NF between 2018 and 2020 in a single medical center in southern Taiwan. Medical records were collected for the evaluation of patients with thrombocytopenia. Univariate and multivariate analyses were performed for different outcomes.
We included 115 patients with confirmed diagnoses of NF. Twelve patients died with a mortality rate of 10.4%. Patients with thrombocytopenia exhibited a higher mortality rate (20.9% vs 4.2%, P = 0.006), more shock episodes (51.2% vs 11.1%, P < 0.001), higher intensive care unit admission rate (46.5% vs 13.9%, P < 0.001), and longer hospital length of stay (37.49 ± 24.12 days vs 28.82 ± 14.63 days, P = 0.037) than those without thrombocytopenia. All patients infected with Vibrio species exhibited thrombocytopenia. In multivariate analysis, independent risk factors for mortality were thrombocytopenia (odds ratio, 4.57; 95% confidence interval, 1.08-19.25) and single gram-negative bacterial culture from the wound (odds ratio 6.88; 95% confidence interval, 1.58-29.96).
In patients with NF and subsequent thrombocytopenia, a higher mortality rate, greater numbers of shock episodes, higher demand for intensive care unit, and longer hospital length of stay were observed than in those without thrombocytopenia. In patients with NF, platelet count is a valuable and economic indicator of prognosis. Once thrombocytopenia developed in patients with necrotizing fasciitis, aggressive antibiotic treatment and surgical management are required to improve the chances of recovery.
坏死性筋膜炎(NF)是一种具有暴发性表现的危及生命的疾病。尽管通过结合体格检查、实验室风险指标坏死性筋膜炎评分和计算机断层扫描可以帮助早期诊断,但仍有 30%的死亡率报告。在现代,一种用于预测 NF 患者死亡率的经济有效的生物标志物仍然缺乏。血小板计数通常在常规血液检查中测量,有助于预测疾病的严重程度。我们旨在阐明血小板计数作为预测 NF 患者死亡率和手术结果等预后因素的指标的作用。
我们在台湾南部的一家单一医疗中心确定了 2018 年至 2020 年间 285 名 NF 患者。收集了病历以评估血小板减少症患者。进行了单变量和多变量分析以评估不同结局。
我们纳入了 115 名确诊为 NF 的患者。12 例患者死亡,死亡率为 10.4%。血小板减少症患者的死亡率更高(20.9%比 4.2%,P=0.006),休克发作更多(51.2%比 11.1%,P<0.001),重症监护病房入住率更高(46.5%比 13.9%,P<0.001),住院时间更长(37.49±24.12 天比 28.82±14.63 天,P=0.037)。所有感染弧菌的患者均出现血小板减少症。多变量分析显示,死亡率的独立危险因素为血小板减少症(优势比,4.57;95%置信区间,1.08-19.25)和伤口单一革兰氏阴性细菌培养(优势比,6.88;95%置信区间,1.58-29.96)。
在 NF 患者中,随后出现血小板减少症的患者与无血小板减少症患者相比,死亡率更高,休克发作次数更多,对重症监护病房的需求更高,住院时间更长。在 NF 患者中,血小板计数是预后的一个有价值且经济的指标。一旦坏死性筋膜炎患者出现血小板减少症,需要积极的抗生素治疗和手术治疗,以提高康复机会。